» Articles » PMID: 10366594

Morphological Differentiation of Oligodendrocytes Requires Activation of Fyn Tyrosine Kinase

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 1999 Jun 15
PMID 10366594
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

In the central nervous system, myelination of axons occurs when oligodendrocyte progenitors undergo terminal differentiation and initiate process formation and axonal ensheathment. Although it is hypothesized that neuron-oligodendrocyte contact initiates this process, the molecular signals are not known. Here we find that Fyn tyrosine kinase activity is upregulated very early during oligodendrocyte progenitor cell differentiation. Concomitant with this increase is the appearance of several tyrosine phosphorylated proteins present only in differentiated cells. The increased tyrosine kinase activity is specific to Fyn, as other Src family members are not active in oligodendrocytes. To investigate the function of Fyn activation on differentiation, we used Src family tyrosine kinase inhibitors, PP1 and PP2, in cultures of differentiating oligodendrocyte progenitors. Treatment of progenitors with these compounds prevented activation of Fyn and reduced process extension and myelin membrane formation. This inhibition was reversible and not observed with related inactive analogues. A similar effect was observed when a dominant negative Fyn was introduced in progenitor cells. These findings strongly suggest that activation of Fyn is an essential signaling component for the morphological differentiation of oligodendrocytes.

Citing Articles

Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours.

Xu C, Tang Y, Lu X, Chen R Front Pharmacol. 2024; 15:1485919.

PMID: 39697541 PMC: 11652172. DOI: 10.3389/fphar.2024.1485919.


Neonatal Brain Injury Triggers Niche-Specific Changes to Cellular Biogeography.

Tahmasian N, Feng M, Arbabi K, Rusu B, Cao W, Kukreja B eNeuro. 2024; 11(12).

PMID: 39681473 PMC: 11680506. DOI: 10.1523/ENEURO.0224-24.2024.


Emerging roles of oligodendrocyte precursor cells in neural circuit development and remodeling.

Buchanan J, da Costa N, Cheadle L Trends Neurosci. 2023; 46(8):628-639.

PMID: 37286422 PMC: 10524797. DOI: 10.1016/j.tins.2023.05.007.


Post-injury born oligodendrocytes incorporate into the glial scar and contribute to the inhibition of axon regeneration.

Xing J, Lukomska A, Rheaume B, Kim J, Sajid M, Damania A Development. 2023; 150(8).

PMID: 36971369 PMC: 10163352. DOI: 10.1242/dev.201311.


Unraveling the Mechanisms of Clinical Drugs-Induced Neural Tube Defects Based on Network Pharmacology and Molecular Docking Analysis.

Guan Z, Liang Y, Wang X, Zhu Z, Yang A, Li S Neurochem Res. 2022; 47(12):3709-3722.

PMID: 35960485 DOI: 10.1007/s11064-022-03717-7.


References
1.
McKinnon R, Matsui T, Dubois-Dalcq M, Aaronson S . FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron. 1990; 5(5):603-14. DOI: 10.1016/0896-6273(90)90215-2. View

2.
Waxman S . Demyelinating diseases--new pathological insights, new therapeutic targets. N Engl J Med. 1998; 338(5):323-5. DOI: 10.1056/NEJM199801293380610. View

3.
Boschek C, Jockusch B, Friis R, BACK R, Grundmann E, Bauer H . Early changes in the distribution and organization of microfilament proteins during cell transformation. Cell. 1981; 24(1):175-84. DOI: 10.1016/0092-8674(81)90513-4. View

4.
Waxman S . Axon-glia interactions: building a smart nerve fiber. Curr Biol. 1997; 7(7):R406-10. DOI: 10.1016/s0960-9822(06)00203-x. View

5.
Umemori H, Wanaka A, Kato H, Takeuchi M, Tohyama M, Yamamoto T . Specific expressions of Fyn and Lyn, lymphocyte antigen receptor-associated tyrosine kinases, in the central nervous system. Brain Res Mol Brain Res. 1992; 16(3-4):303-10. DOI: 10.1016/0169-328x(92)90239-8. View